Medium-Chain Triglyceride
Definition and meaning of Medium-Chain Triglyceride in chemistry.
Medium-chain triglyceride (MCT) is a type of dietary fat consisting of a glycerol backbone bonded to three fatty acids that each contain 6 to 12 carbon atoms. MCTs occur naturally in coconut oil and palm kernel oil, and commercial MCT oil is produced by fractionating those oils to concentrate the medium-chain fatty acids.
In more detail
MCTs are rapidly absorbed in the small intestine and metabolized directly by the liver, unlike longer-chain fats that require more extensive digestion and emulsification. This efficient absorption makes MCTs valuable in clinical nutrition for patients with pancreatic insufficiency or malabsorption disorders. MCTs are also used in ketogenic diets and sports nutrition formulations.
Key facts
| Chain length | 6-12 carbon atoms per fatty acid |
|---|---|
| Tricaprylin formula | C27H50O6 |
| Field | Biochemistry |
| Natural sources | Coconut oil, palm kernel oil, dairy fat |
Tricaprylin, a triglyceride composed of three caprylic acid (C8) chains, is a major component of commercial MCT oil, which is typically manufactured from fractionated coconut or palm kernel oil and commonly used in medical nutrition supplements. In whole, unrefined coconut oil, however, lauric acid (C12) is the most abundant fatty acid by far (roughly 45-53% of total fatty acids), well ahead of caprylic acid (about 7-8%).
Frequently asked questions
How do MCTs differ from regular fats in the body?
MCTs require less bile-salt emulsification and micelle formation than long-chain triglycerides. After partial hydrolysis by pancreatic lipase, the resulting medium-chain fatty acids can be absorbed directly across the intestinal wall and transported via the portal vein straight to the liver, rather than being repackaged into chylomicrons and carried through the lymphatic system like long-chain fats.
Why are MCTs used in medical nutrition?
MCTs are rapidly metabolized for energy and effectively absorbed even when normal fat digestion is impaired, benefiting patients with cystic fibrosis, malabsorption, or post-surgical conditions.